SC
GMO

Sophrosyne Capital’s General Moly, Inc. GMO Stock Holding History

Sophrosyne Capital’s Portfolio GMO Stock Details GMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-16,000
Closed -$11K – 12
2015
Q2 		$11K Buy
+16,000
New +$11.4K 0.08% 15

Other funds holding GMO

UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SIM
Sonora Investment Management Tucson, Arizona $798M AUM 17.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FIM
Fernwood Investment Management Quincy, Massachusetts $288M AUM 33.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sophrosyne Capital's GMO Position: Q3 2015 in Review

Sophrosyne Capital sold out of General Moly, Inc. (GMO) in Q3 2015, closing a stake of 16,000 shares — an estimated $11K sold.

Sophrosyne Capital first reported a position in GMO in Q2 2015 and held it in 1 quarter. The position peaked at $11K in Q2 2015. 33 funds tracked by Wall St. Rank hold GMO as of Q3 2015.

  • Sophrosyne Capital reported no remaining General Moly, Inc. position as of Q3 2015 after selling out during the quarter.
  • Sophrosyne Capital sold 16,000 General Moly, Inc. shares in Q3 2015, an estimated $11K.
  • Sophrosyne Capital first reported a position in General Moly, Inc. in Q2 2015 and held it in 1 quarter.
  • Sophrosyne Capital's General Moly, Inc. position peaked at $11K in Q2 2015.
  • 33 funds tracked by Wall St. Rank held General Moly, Inc. as of Q3 2015.

Based on Sophrosyne Capital's 13F filing for Q3 2015, filed 13 Nov 2015.